Inventor · disambiguated record
Ulrich Werner
Also filed as: WERNER ULRICH
21 granted patents·19 pending applications·338 citations·filing 1992–2025
94Inventor score
Top patents by PatentIndex Score
40 records- 0195US6093730ASubstituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticalsHOECHST MARION ROUSSEL DE GMBH·Filed 1998·Granted Jul 25, 2000·184 cites·37 claims
- 0290US7008957B2Bicyclic cyanoheterocycles, process for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Mar 7, 2006·30 cites·10 claims
- 0387US8633156B2Insulin derivatives having an extremely delayed time-action profileHABERMANN PAUL·Filed 2010·Granted Jan 21, 2014·18 cites·27 claims
- 0487US7094800B2Cyanopyrrolidides, process for their preparation and their use as medicamentsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Aug 22, 2006·20 cites·10 claims
- 0584US2024108692A1Combination of an insulin and a glp-1-agonistSANOFI AVENTIS DEUTSCHLAND·Filed 2023·Application pending·0 cites
- 0683US9526764B2Combination of an insulin and a GLP-1-agonistWERNER ULRICH·Filed 2009·Granted Dec 27, 2016·11 cites·15 claims
- 0781US10117909B2Combination of an insulin and a GLP-1 agonistSANOFI AVENTIS DEUTSCHLAND·Filed 2016·Granted Nov 6, 2018·3 cites·8 claims
- 0881US5556856APhthalazinone derivatives that modulate multi-drug resistanceASTA MEDICA AG·Filed 1995·Granted Sep 17, 1996·56 cites·5 claims
- 0980US8003668B2Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disordersSANOFI AVENTIS·Filed 2007·Granted Aug 23, 2011·4 cites·2 claims
- 1079US11090364B2Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing proteinSANOFI SA·Filed 2017·Granted Aug 17, 2021·1 cites·26 claims
- 1176US9345750B2Long-acting formulations of insulinSANOFI SA·Filed 2014·Granted May 24, 2016·2 cites·59 claims
- 1275US8138207B2Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositionsDEFOSSA ELISABETH·Filed 2007·Granted Mar 20, 2012·2 cites·2 claims
- 1375US2025206798A1Insulin conjugatesSANOFI SA·Filed 2024·Application pending·0 cites
- 1474US11098102B2Insulin conjugatesSANOFI SA·Filed 2019·Granted Aug 24, 2021·1 cites·24 claims
- 1574US7569700B2Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicamentsSANOFI AVENTIS·Filed 2007·Granted Aug 4, 2009·2 cites·16 claims
- 1674US2020215163A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2019·Application pending·0 cites
- 1774US2025161416A1Combination of an insulin and a glp-1-agonistSANOFI AVENTIS DEUTSCHLAND·Filed 2025·Application pending·0 cites
- 1872US2021308225A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2021·Application pending·0 cites
- 1971US8163774B2Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicamentsDEFOSSA ELISABETH·Filed 2007·Granted Apr 24, 2012·1 cites·2 claims
- 2071US2021401946A1Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing proteinSANOFI SA·Filed 2021·Application pending·0 cites
- 2171US2022016217A1Combination of an insulin and a glp-1-agonistSANOFI AVENTIS DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 2271US2021401947A1Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing proteinSANOFI SA·Filed 2021·Application pending·0 cites
- 2369US2020384087A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2020·Application pending·0 cites
- 2466US2019388511A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2019·Application pending·0 cites
- 2565US7888343B2Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidaseSANOFI A VENTIS DEUTSCHLAND GMBH·Filed 2007·Granted Feb 15, 2011·1 cites·8 claims
- 2665US2019046616A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2018·Application pending·0 cites
- 2761US2019192635A1Combination of an insulin and a glp-1-agonistSANOFI AVENTIS DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2858US2016339084A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2016·Application pending·0 cites
- 2958US2016228516A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2016·Application pending·0 cites
- 3057US2015164999A1Long-Acting Formulations of InsulinSANOFI SA·Filed 2015·Application pending·0 cites
- 3155US2012122774A1Long-acting formulations of insulinsBECKER REINHARD·Filed 2011·Application pending·0 cites
- 3254US2011301081A1Long-acting formulations of insulinsBECKER REINHARD·Filed 2011·Application pending·0 cites
- 3350US7795445B2Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their useSANOFI AVENTIS·Filed 2007·Granted Sep 14, 2010·0 cites·4 claims
- 3450US2015119323A1Stable Formulation of Insulin GlulisineSANOFI SA·Filed 2014·Application pending·0 cites
- 3547US7879864B2Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetesSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Feb 1, 2011·0 cites·8 claims
- 3647US7838528B2Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their useSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Nov 23, 2010·0 cites·7 claims
- 3746US2018036411A1Stable Formulation of Insulin GlulisineSANOFI SA·Filed 2017·Application pending·0 cites
- 3843US5354750APhthalazines containing an aromatic ether or thioether group in the 1-positionASTA MEDICA AG·Filed 1992·Granted Oct 11, 1994·2 cites·3 claims
- 3939US8236810B2Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IVSCHOENAFINGER KARL·Filed 2007·Granted Aug 7, 2012·0 cites·4 claims
- 4035US9644017B2Insulin derivatives having an extremely delayed time-action profileHABERMANN PAUL·Filed 2010·Granted May 9, 2017·0 cites·37 claims
Join the waitlist — get patent alerts
Get an alert when Ulrich Werner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →